⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
globenewswire.com
ALVO
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
globenewswire.com
ALVO
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
globenewswire.com
ALVO
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
globenewswire.com
ALVO
Alvotech announces successful closure of FDA inspection of manufacturing facility
globenewswire.com
ALVO
Alvotech announces successful closure of FDA inspection of manufacturing facility
globenewswire.com
ALVO
Transactions of Managers and Closely Associated Persons
globenewswire.com
ALVO
Alvotech further strengthens liquidity by securing term loan facility of $75 million
globenewswire.com
ALVO
Alvotech further strengthens liquidity by securing term loan facility of $75 million
globenewswire.com
ALVO
Transactions of Managers and Closely Associated Persons
globenewswire.com
ALVO